Last update 08 Nov 2025

LCAR-BCDR(Nanjing Legend Biotechnology)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
BCMAtargeted CART therapy(Nanjing Legend Biotech)
Target
BCMA
Action
inhibitors
Mechanism
BCMA inhibitors(B-cell maturation protein inhibitors), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Multiple Myeloma
Inactive Indication
Refractory Multiple MyelomaRelapse multiple myeloma
Originator Organization
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
Active Organization
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with LCAR-BCDR(Nanjing Legend Biotechnology)
NCT05376345
/ TerminatedPhase 1IIT
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BCMA-targeted LCAR-BCDR Cells Product in Patients With Relapsed/Refractory Multiple Myeloma
NCT03672253
/ Unknown statusPhase 1IIT
Study of CAR-T Cells Targeting BCMA for Previously CAR-T Treated Refractory/Relapsed Multiple Myeloma
100 Clinical Results associated with LCAR-BCDR(Nanjing Legend Biotechnology)
Login to view more data
100 Translational Medicine associated with LCAR-BCDR(Nanjing Legend Biotechnology)
Login to view more data
100 Patents (Medical) associated with LCAR-BCDR(Nanjing Legend Biotechnology)
Login to view more data
100 Deals associated with LCAR-BCDR(Nanjing Legend Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory Multiple MyelomaPhase 1
China
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
01 Sep 2022
Relapse multiple myelomaPhase 1
China
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
26 Jul 2018
Multiple MyelomaPhase 1
China
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free